235 related articles for article (PubMed ID: 15834405)
1. In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe.
Hintersteiner M; Enz A; Frey P; Jaton AL; Kinzy W; Kneuer R; Neumann U; Rudin M; Staufenbiel M; Stoeckli M; Wiederhold KH; Gremlich HU
Nat Biotechnol; 2005 May; 23(5):577-83. PubMed ID: 15834405
[TBL] [Abstract][Full Text] [Related]
2. Bringing amyloid into focus.
Golde TE; Bacskai BJ
Nat Biotechnol; 2005 May; 23(5):552-4. PubMed ID: 15877070
[No Abstract] [Full Text] [Related]
3. Efficient near-infrared in vivo imaging of amyoid-β deposits in Alzheimer's disease mouse models.
Schmidt A; Pahnke J
J Alzheimers Dis; 2012; 30(3):651-64. PubMed ID: 22460331
[TBL] [Abstract][Full Text] [Related]
4. In vivo detection of amyloid plaques in the mouse brain using the near-infrared fluorescence probe THK-265.
Okamura N; Mori M; Furumoto S; Yoshikawa T; Harada R; Ito S; Fujikawa Y; Arai H; Yanai K; Kudo Y
J Alzheimers Dis; 2011; 23(1):37-48. PubMed ID: 20930313
[TBL] [Abstract][Full Text] [Related]
5. Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques.
Li Q; Min J; Ahn YH; Namm J; Kim EM; Lui R; Kim HY; Ji Y; Wu H; Wisniewski T; Chang YT
Chembiochem; 2007 Sep; 8(14):1679-87. PubMed ID: 17705341
[TBL] [Abstract][Full Text] [Related]
6. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
8. Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease.
Ono M; Maya Y; Haratake M; Ito K; Mori H; Nakayama M
Biochem Biophys Res Commun; 2007 Sep; 361(1):116-21. PubMed ID: 17644062
[TBL] [Abstract][Full Text] [Related]
9. Selective vulnerability of different types of commissural neurons for amyloid beta-protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology.
Capetillo-Zarate E; Staufenbiel M; Abramowski D; Haass C; Escher A; Stadelmann C; Yamaguchi H; Wiestler OD; Thal DR
Brain; 2006 Nov; 129(Pt 11):2992-3005. PubMed ID: 16844716
[TBL] [Abstract][Full Text] [Related]
10. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes.
Nilsson KP; Aslund A; Berg I; Nyström S; Konradsson P; Herland A; Inganäs O; Stabo-Eeg F; Lindgren M; Westermark GT; Lannfelt L; Nilsson LN; Hammarström P
ACS Chem Biol; 2007 Aug; 2(8):553-60. PubMed ID: 17672509
[TBL] [Abstract][Full Text] [Related]
11. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
12. A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques.
Elsinghorst PW; Härtig W; Goldhammer S; Grosche J; Gütschow M
Org Biomol Chem; 2009 Oct; 7(19):3940-6. PubMed ID: 19763296
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.
van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D
ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
15. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
[TBL] [Abstract][Full Text] [Related]
16. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
Montalto MC; Farrar G; Hehir CT
Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice.
Frank S; Copanaki E; Burbach GJ; Müller UC; Deller T
Neurosci Lett; 2009 Mar; 453(1):41-4. PubMed ID: 19429012
[TBL] [Abstract][Full Text] [Related]
18. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
Garcia-Alloza M; Robbins EM; Zhang-Nunes SX; Purcell SM; Betensky RA; Raju S; Prada C; Greenberg SM; Bacskai BJ; Frosch MP
Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828
[TBL] [Abstract][Full Text] [Related]
19. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
20. Linker histone H1 binds to disease associated amyloid-like fibrils.
Duce JA; Smith DP; Blake RE; Crouch PJ; Li QX; Masters CL; Trounce IA
J Mol Biol; 2006 Aug; 361(3):493-505. PubMed ID: 16854430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
